pharmaceuticals

G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…

For the first time, regulators have approved a small-molecule pill targeting glucagon-like peptide1 (GLP-1) for weight loss.…

Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk rose as much as 4%…

Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug…

Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a…

A clinical trial found that fluvoxamine significantly improved fatigue and quality of life for Long COVID patients with…

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…

Since last fall, Concerta, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been in short…

A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…

Dr. David Fajgenbaum, one of the founders of Every Cure, a nonprofit focused on drug repurposing. Courtesy of…

Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs…

The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…

All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight